[eDisclosure Notice] KOSDAQ - 8th

▲Barun Electronics=Announced that the formal delisting reason has been resolved as the audit opinion was changed to unqualified regarding last year's audit report submission.

▲HiJe 5th SPAC=Announced that it was designated as a management item for failing to submit the preliminary listing examination application by six months before the expiration of the existence period, and if the application is not submitted by the 15th, it will be subject to delisting criteria.

▲Redrover=Announced the commencement of orderly trading due to delisting. The delisting date is the 21st.

▲Yeon E B&T=Announced that an additional reason for the substantial review of listing eligibility has been added due to the disclosure of embezzlement and breach of trust allegations.

▲S&W=The KOSDAQ Market Committee reviewed and resolved to grant an 8-month improvement period.

▲Qurient=Applied to the Korea Ministry of Food and Drug Safety for a Phase 1B/2 clinical trial of the immuno-oncology drug Q702 in combination with Pembrolizumab (Keytruda).